Skip to main content
. 2017 Apr;22(2):119–126. doi: 10.17712/nsj.2017.2.20160330

Table 1.

Demographic and clinical characteristics of all patients (N=250).

Variables n (%)
Age (years) 72.3±11.8 (35-97)
Gender
 Female 124 (49.6)
 Male 126 (50.4)
Co-morbidity
 Hypertension 185 (74.0)
 Coronary artery disease 100 (40.0)
 Diabetes mellitus  74 (29.6)
 Cardiac heart failure  42 (16.8)
 Hyperlipidemia  39 (15.6)
 Chronic obstructive pulmonary disease  25 (10.0)
 Other 138 (55.2)
 Smoking  73 (29.2)
Latency  8 (2-120)
TOAST
 Large artery disease  22  (8.8)
 Cardioembolism  29 (11.6)
 Small artery disease (lacune)  40 (16.0)
 Stroke of other determined 0 -
 Stroke of undetermined 159 (63.6)
mRS
 No significant disability  46 (18.4)
 Slight disability  86 (34.4)
 Moderate disability  49 (19.6)
 Moderate-severe disability  20  (8.0)
 Severe disability  13  (5.2)
 Dead  36 (14.4)
NIHSS  6 (1-18)
Latency (mean)(h) 13.77±17.14 (2-120)
Hospitalization days  4 (1-116)
TIV(h) 4.0±9.2 (0-65 hours)
MPV (mean) 8.7 (4.4-15.7)

SD - standard deviation, min - minimum, max - maximum, TOAST - The Trial Of Org 10172 in Acute Stroke Treatment, mRS - modified Rankin scale, NIHSS - National Institutes of Health Stroke Scale, TIV - time interval of venipuncture, MPV - mean platelet volume